Protein engineering and preclinical development of a <scp>GM</scp>‐<scp>CSF</scp> receptor antibody for the treatment of rheumatoid arthritis

Abstract

This rational approach to antibody drug discovery enabled the isolation of a potent molecule compatible with chronic, s.c. self-administration by RA patients. We believe this general approach enables the development of optimal biopharmaceuticals.